Ignite Creation Date:
2024-05-05 @ 4:55 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00340704
Status:
COMPLETED
Last Update Posted:
2016-02-17
First Post:
2006-06-19
Brief Title:
PKPD Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Study Overview
Official Title:
An Uncontrolled Open-label Titration Long-term Safety up to 12 Months and Efficacy Study of Tamsulosin Hydrochloride in Children With Neuropathic Bladder With a Randomized Pharmacokinetic Sub-study Investigating Low Medium and High Dose Ranges
Status:
COMPLETED
Status Verified Date:
2016-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Aims of this study is to characterize the pharmacokineticpharmacodynamic profile and evaluate the safety efficacy and tolerability of tamsulosin hydrochloride as treatment in children with a neuropathic bladder over the course of 12 months of active treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None